Q7LCB3 (Q7LCB3_HUMAN) Homo sapiens (Human)

Estrogen receptor beta UniProtKBInterProInteractive Modelling

530 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: Q92731

Available Structures

37 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH KB095285 AND CIA12 COACTIVATOR P… Heteromer
Q92731; Q9HCD5;
262-502
KB0;
Assess
Crystal Structure of Estrogen Receptor beta complexed with WAY-338 Heteromer
Q15788; Q92731;
263-501
338;
Assess
Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555 Heteromer
Q15788; Q92731;
263-500
555;
Assess
Crystal structure of estrogen receptor beta complexed with 3-Bromo-6-hydroxy-2-(4-hydroxy-phenyl)-i… Heteromer
Q15788; Q92731;
263-500
789;
Assess
Crystal structure of phosphorylated estrogen receptor beta ligand binding domain Heteromer
Q15788; Q92731;
262-498
EST;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with S-DPN Heteromer
Q15788; Q92731;
263-498
I0K;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R)-2-(2-chloro-4-hydroxyphenyl)… Heteromer
Q15788; Q92731;
263-498
I1M;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (S)-3-(2-chloro-4-hydroxyphenyl)… Heteromer
Q15788; Q92731;
263-498
I1I;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R)-3-(2-chloro-4-hydroxyphenyl)… Heteromer
Q15788; Q92731;
263-498
I1D;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (S)-2-(2-chloro-4-hydroxyphenyl)… Heteromer
Q15788; Q92731;
263-498
I2B;
Assess
Stapled peptide bound to Estrogen Receptor Beta Heteromer
Q15596; Q92731;
263-497
YJD;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 Heteromer
Q15788; Q92731;
263-497
697;
Assess
Crystal Structure of Estrogen Receptor beta complexed with WAY-797 Heteromer
Q15788; Q92731;
263-497
797;
Assess
Crystal structure of estrogen receptor beta complexed with 1-chloro-6-(4-hydroxy-phenyl)-naphthalen… Heteromer
Q15788; Q92731;
263-497
4NA;
Assess
Fragment-Based Design of novel Estrogen Receptor Ligands Heteromer
Q15788; Q92731;
264-497
W23;
Assess
Fragment-Based Design of novel Estrogen Receptor Ligands Heteromer
Q15788; Q92731;
264-497
W14;
Assess
Crystal structure of estrogen receptor beta ligand binding domain Heteromer
Q15788; Q92731;
264-497
EST;
Assess
Fragment-Based Design of novel Estrogen Receptor Ligands Heteromer
Q15788; Q92731;
264-497
WV7;
Assess
A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen recept…homo-2-mer260-501
OHT;
Assess
Estrogen receptor beta ligand binding domain in complex with a Benzopyran agonisthomo-2-mer260-501
JJ3;
Assess
HUMAN OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PARTIAL AGONIST GENISTEINhomo-2-mer260-500
GEN;
Assess
Human estrogen receptor beta ligand-binding domain in complex with compound 45homo-2-mer260-500
FBR;
Assess
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligandhomo-2-mer260-500
DC8;
Assess
Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligandhomo-2-mer260-500
3AS;
Assess
Crystal Structure of ER beta bound to Estradiolhomo-2-mer262-501
EST;
Assess
Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of…homo-2-mer260-498
I0G;
Assess
Sulfonamides as selective Estrogen Receptor beta Agonists.homo-2-mer260-498
SU4;SO4;
Assess
Crystal structure of estrogen receptor beta complexed with way-202196homo-2-mer263-500
196;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244homo-2-mer263-500
244;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041homo-2-mer263-500
041;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEINhomo-2-mer263-497
GEN;
Assess
Crystal Structure of Estrogen Receptor beta complexed with CL-272homo-2-mer263-497
272;
Assess
Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12…monomer261-501
ETC;
Assess
Estrogen Receptor beta with Selective Triazine Modulatormonomer261-500
MON;
Assess
Estrogen Receptor in complex with proline-flanked LXXLL peptidesmonomer261-498
EST;
Assess
Estrogen Receptor in complex with proline-flanked LXXLL peptidesmonomer262-498
EST;
Assess
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397monomer263-497
397;
Assess

15 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7prw.1.Bmonomer0.61146-500
ZN;30.21
Assess
7prw.1.Amonomer0.60143-500
ZN;30.21
Assess
7wnh.4.Amonomer0.60149-498
ZN;26.71
Assess
7wnh.2.Amonomer0.60148-495
ZN;26.71
Assess
5uan.1.Bmonomer0.59148-496
ZN;27.40
Assess
7kw7.1.Fmonomer0.59253-501
30.21
Assess
4nqa.1.Amonomer0.58147-496
ZN;34.88
Assess
5uan.1.Amonomer0.58147-497
ZN;32.93
Assess
4nqa.2.Amonomer0.58142-498
ZN;32.93
Assess
4nqa.2.Bmonomer0.58144-497
ZN;25.58
Assess
4iqr.1.Bmonomer0.57147-497
ZN;29.15
Assess
4iqr.1.Amonomer0.57147-497
ZN;29.15
Assess
3dzy.1.Amonomer0.57146-495
ZN;32.42
Assess
4nqa.1.Bmonomer0.57144-496
ZN;25.58
Assess
3dzu.1.Bmonomer0.55146-497
23.10
Assess